Owens & Minor, Inc. (NYSE:OMI) Receives $18.50 Consensus Price Target from Brokerages

Owens & Minor, Inc. (NYSE:OMI - Get Free Report) has been given a consensus recommendation of "Hold" by the eight ratings firms that are covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, four have given a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $18.50.

Several analysts recently weighed in on OMI shares. UBS Group cut their price target on shares of Owens & Minor from $28.00 to $25.00 and set a "buy" rating on the stock in a report on Tuesday, November 5th. Robert W. Baird cut their target price on shares of Owens & Minor from $15.00 to $14.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 4th. Citigroup decreased their price target on shares of Owens & Minor from $21.00 to $18.50 and set a "buy" rating for the company in a research note on Tuesday, November 5th. Finally, Barclays lowered their price objective on shares of Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating for the company in a report on Tuesday, November 5th.

Owens & Minor Trading Down 2.6 %

Shares of OMI stock traded down $0.22 during trading hours on Friday, reaching $8.20. The company's stock had a trading volume of 974,213 shares, compared to its average volume of 1,006,314. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11. Owens & Minor has a one year low of $8.08 and a one year high of $28.35. The stock has a market capitalization of $632.30 million, a P/E ratio of -12.62, a P/E/G ratio of 0.25 and a beta of 0.48. The firm's fifty day simple moving average is $13.18 and its 200 day simple moving average is $13.99.

Insider Buying and Selling at Owens & Minor

In other news, CFO Jonathan A. Leon sold 5,282 shares of the stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $11.82, for a total value of $62,433.24. Following the sale, the chief financial officer now directly owns 130,822 shares of the company's stock, valued at approximately $1,546,316.04. This represents a 3.88 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 3.59% of the company's stock.

Hedge Funds Weigh In On Owens & Minor

Hedge funds have recently bought and sold shares of the company. Royce & Associates LP increased its holdings in shares of Owens & Minor by 179.4% in the 3rd quarter. Royce & Associates LP now owns 80,914 shares of the company's stock worth $1,270,000 after purchasing an additional 51,955 shares in the last quarter. FMR LLC boosted its position in shares of Owens & Minor by 0.8% during the third quarter. FMR LLC now owns 11,564,624 shares of the company's stock valued at $181,449,000 after buying an additional 90,862 shares during the last quarter. Waldron Private Wealth LLC purchased a new stake in shares of Owens & Minor during the fourth quarter valued at $406,000. JPMorgan Chase & Co. increased its holdings in Owens & Minor by 68.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 376,830 shares of the company's stock worth $5,912,000 after buying an additional 152,999 shares in the last quarter. Finally, Foundry Partners LLC purchased a new position in Owens & Minor in the 3rd quarter worth about $5,238,000. Institutional investors own 98.04% of the company's stock.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.